Mortality risk in adults with intellectual disabilities and epilepsy: an England and Wales case–control study

Abstract

Background People with epilepsy (PWE) and people with intellectual disabilities (ID) both live shorter lives than the general population and both conditions increase the risk of death further. We aimed to measure associations between certain risk factors for death in PWE and ID. Methods A retrospective case-control study was conducted in ten regions in England and Wales. Data were collected on PWE registered with secondary care ID and neurology services between 2017 and 2021. Prevalence rates of neurodevelopmental, psychiatric and medical diagnoses, seizure frequency, psychotropic and antiseizure medications (ASM) prescribed, and health activity (epilepsy reviews/risk assessments/care plans/compliance etc.) recorded were compared between the two groups. Results 190 PWE and ID who died were compared with 910 living controls. People who died were less likely to have had an epilepsy risk assessment but had a greater prevalence of genetic conditions, older age, poor physical health, generalized tonic-clonic seizures, polypharmacy (not ASMs) and antipsychotic use. The multivariable logistic regression for risk of epilepsy-related death identified that age over 50, medical condition prevalence, antipsychotic medication use and the lack of an epilepsy review in the last 12 months as associated with increased risk of death. Reviews by psychiatrists in ID services was associated with a 72% reduction in the odds of death compared neurology services. Conclusions Polypharmacy and use of antipsychotics may be associated with death but not ASMs. Greater and closer monitoring by creating capable health communities may reduce the risk of death. ID services maybe more likely to provide this holistic approach. James J. Sun, Lance Watkins have contributed equally to this work.

Chronic constipation in people with intellectual disabilities in the community: cross-sectional study

“… 12 Furthermore, in a recent case–control study comparing a group of people with epilepsy and intellectual disability who had died with live controls from the same population, the authors identified significant differences in antipsychotic prescribing and overall polypharmacy as major modifiable factors. 13 The links of these factors (antipsychotics, anti-epileptics and polypharmacy) to premature mortality in people with intellectual disabilities and their links in our study to constipation needs to be highlighted.…”

Laxative use in adults with intellectual disabilities: development of prescribing guidelines

“…People with intellectual disabilities are predisposed to bowel problems because of higher levels of multimorbidity and polypharmacy. 22 , 25 Constipation is a significant issue for the intellectual disability population, and can lead to serious complications. 16 The England Learning Disability Mortality Review has highlighted that nearly a quarter of people with intellectual disabilities who were reviewed for premature mortality had constipation.…”

Patterns of antiseizure medications prescribing in people with intellectual disability and epilepsy: A narrative review and analysis

“…Many PwID with a past history of epilepsy remain seizure free and should be considered for ASM withdrawal. Given the multi-dimensional challenges at the patient, clinician and resource level, 59,60 this remains a poorly engaged topic but requires more research and coproduced engagement to reduce and prevent iatrogenic harm.…”